Our Company, Our Values, and a Key Proposition
Our three-year vision (2026): Modernize 1,000 ORs for the wireless era.
Meet Team Lazurite.
Our Mission
Solve impossible problems to improve people’s lives
We pursue success and satisfaction by:
- Dedicating ourselves to better outcomes for all participants in the healthcare system.
- Forging authentic, meaningful relationships.
- Working diligently and collaboratively to foster moments of serendipity.
Our Company
Mr. Eugene Malinskiy is one of our co-founders (est. 2015) and our Chief Executive Officer. Prior to Lazurite, he served as the founder and CEO of DragonID, LLC, a healthcare innovation and engineering consultancy specializing in medical devices for orthopedics and cardiology.
Ms. Leah Brownlee joined our company in her current roles in October 2020. She currently serves as board chair of Switch Automation (US), Inc. and her previous positions include of counsel in the global corporate department at Squire Patton Boggs (US) LLP, a top-20 global law firm and executive vice president of compliance and operations at Cleveland Biolabs (NASDAQ: CBLI).
Mr. Neil Lyons joined our company in June 2023. He started his career with Deloitte and practiced as a CPA with them for more than 10 years. From 2005 to 2021, Neil served as the CFO for three life science companies, two public and one private. Since then, Mr. Lyons has worked with life science companies on a fractional basis.
Mr. Jerry Deluca joined Lazurite in February 2024. His other roles include managing partner at Vergil Ventures and distinguished venture partner at NextGen Venture Partners, where he has served as a key figure in healthcare innovation. With his extensive leadership experience at companies such as Arthrex and Intuitive Surgical, Jerry brings a wealth of strategic insights to bear on the intricacies of the ever-evolving, health-tech sector.
Mr. Dan Nelson joined our company in his current role in 2018. His previous positions include senior product manager at Volk Optical Inc., project manager at DXY Solutions, LLC, and sergeant in the US Air Force.
Mr. Patrick Polito, a certified quality auditor, joined our company in 2016. His previous positions include manager of client services at iuvo BioScience, microbiologist, and validation specialist. He has spent many years in both client and regulatory agency facing positions.
Our Medical Advisors
Dr. Jazrawi is chief of the sports medicine division at NYU Langone Health, as well as the team physician for NYU athletics and Long Island University athletics. He specializes in the surgical management of sports injuries, and has substantial experience in the care of pitchers in particular, and other athletes with injuries due to overhead throwing.
Laith Jazrawi, MD
NYU Langone Health
Dr. Proctor is an orthopaedic surgeon at De La Vina Surgicenter. His previous roles include stadium physician for the New York Yankees, as well as consulting physician for the US Ski Team and UC Santa Barbara athletics. He has developed and patented devices that prevent and rehabilitate sports injuries, and his current research includes novel techniques to repair shoulders and knees.
Christopher Proctor, MD
De La Vina Surgicenter
Dr. Schickendantz is program director of orthopedic surgery for the Cleveland Clinic Sports Health. He is also the head team physician of the Cleveland Guardians. His specialties include sports medicine and arthroscopic surgery of the shoulder and elbow. His memberships include the American Board of Orthopedic Surgery and the MLB Team Physicians Association.
Mark Schickendantz, MD
The Cleveland Clinic
Dr. Voos currently serves as chair of the orthopedics departments at University Hospitals and Case Western Reserve University, which includes overseeing their renowned orthopedic training programs and research divisions. He was recently elected vice president of the NFL® Physicians Society and serves as the team physician for the Cleveland Browns™.
James Voos, MD
University Hospital (CLE)
Our Board
Dr. Mark Froimson is principal of Riverside Health Advisors, with a specialty in financing and accelerating healthcare innovation. In this capacity, he serves as chief medical officer for AngelMD, as chair for the boards of Lazurite and Thrive, and on the boards of Pacira Biosciences, Inc., Sintx Technologies, Inc., and multiple nonprofit organizations, including the National Board of the Arthritis Foundation. He also serves as an advisor to numerous healthcare provider and technology companies.
As executive vice president and chief clinical officer for Trinity Health, Dr. Froimson managed physician, nursing and pharmacy services, quality, safety, patient experience and alternate payment strategies for the clinical enterprise. For 16 years, he was a member of the faculty of the Department of Orthopedic Surgery at the Cleveland Clinic. During that time, he served as president and CEO of Cleveland Clinic’s Euclid Hospital, president of the professional staff of the Cleveland Clinic, vice chair of the Orthopedic and Rheumatologic Institute, and as a member of the Board of Governors and Board of Trustees.
Mark Froimson, MD
Chair
Mr. Gary Cohn is the vice chairman of IBM and the former director of the United States National Economic Council. From January 2017 to April 2018, Mr. Cohn worked as the assistant to President Donald J. Trump for economic policy, director of the National Economic Council, and as chief economic advisor to the president. Mr. Cohn managed the coordination of the president’s domestic and global economic policy agenda and led the administration-wide effort to successfully pass the historic Tax Cuts and Jobs Act of 2017.
In 1990, Mr. Cohn began a distinguished career in finance at the Goldman Sachs Group, Inc. His titles included global co-head of the equities and fixed income, currency, and commodities division, and president and COO from 2006 to 2016. He was also a member of the firm’s board of directors and chairman of the firmwide client and business standards committee.
Gary Cohn
Mr. Jeff Hanson brings over 30 years of financial, advisory, entrepreneurial, and institutional asset management experience to the board. His specialized advisory services firm, Hanson Advisors, partners with businesses spanning financial services, private equity, venture capital, asset management, insurance, technology, and healthcare. Mr. Hanson works closely with founders, partnerships, investors, boards and senior leadership teams to define, achieve, and sustain success across business, market, and organizational life cycles/transitions.
For over 12 years, Mr. Hanson served as a founding member of Milestone Capital Management. In his work with the Goldman Sachs Group, Inc., Mr. Hanson established innovative internal consulting solutions to drive and manage the growth of businesses, clients, and platforms across banking, sales, trading, and operations.
Jeff Hanson
Mr. Michael Salerno has over 20 years of experience as a family wealth and investment professional. He is presently managing partner at AUA Capital Management, which he cofounded in 2013 with Andrew Unanue. Previously, Mr. Salerno served as managing director, partner, and member of the investment and executive committees of QFS Asset Management. He was a cofounder and CIO of Cenario Capital Management, and served as CIO for the Unanue Family Office.
He also worked as the founding managing director and CIO for the predecessor to Select Trust and Asset Management. At the family office for the Ortenzio family (Select Medical Corporation), he served as general partner of Select Capital Ventures, a fund focused on providing growth capital to healthcare-focused companies. Early In his career, Mr. Salerno served as president of M&T Capital, the venture subsidiary of M&T Bank.
Michael Salerno
Mr. Jon Serbousek is the president and CEO of Orthofix. He brings over 30 years of experience in the medical device and biotech industries to the board. His previous roles include senior vice president and officer at Biomet. His duties there included worldwide president of Biomet Biologics, worldwide group president of orthopedics, and president of US orthopedics.
With Medtronic, Mr. Serbousek held multiple positions, including worldwide division president of spine and worldwide vice president and general manager of Biologics. In 13 years at DePuy Orthopedics, a Johnson & Johnson company, Mr. Serbousek served as vice president of marketing and product development and vice president of spinal operations. Mr. Serbousek began his career with a Japanese venture-financed medical device company.
Jon Serbousek
Mr. Malinskiy is a serial entrepreneur. As CEO, his responsibilities include fundraising, investor relations, and long-term strategic vision. He is also responsible for new product development and managing physician/hospital relationships.
Mr. Malinskiy sold his first company, an IT and networking services firm, in 2008. He then founded DragonID, a consultancy group for biomedical engineering and design. Mr. Malinskiy’s work has earned him accolades from Inside Business and Crain’s Cleveland Business. In 2015, he made Forbes’ 30 under 30 in manufacturing list.
Eugene Malinskiy
Co-founder and CEO
Our Philosophy
We established Lazurite to build operating room technology commensurate with the skills of clinicians, in order to improve patient outcomes, boost clinical safety, and improve healthcare efficiency.
To meet these goals, we organize our work around six core values.
01
People first.
We focus on problems in healthcare (not just the healthcare market). We use science, engineering, and design to build durable, substantial solutions. Our rigorous solutions open opportunities in the market.
02
Be present.
Every interaction with an investor, vendor, or partner represents an opportunity to bolster faith in our vision. We take the time to tell our story well, and build personal connections at every opportunity.
03
Be open. Be receptive.
We recognize the need to think anew about persistent challenges, and to seek out creative connections that spark new ideas on the way to serendipitous solutions.
04
Do what it takes, together.
There is no substitute for hard work—or teamwork. We ask each other difficult questions. We connect the dots together, and we celebrate our triumphs together.
05
Some things are not possible, yet.
Through creativity, diligence, and collaboration, we can narrow the gap between today, when a goal is impossible, and the moment it becomes possible.
06
Reliability equals sustainability.
When we say what we mean and deliver the goods, we ensure that we, as a company, thrive.
How We Work
We know surgeons.
They are our stakeholders and our inspiration. Where they see inefficiencies, we see opportunities.
We listen, observe, and integrate.
Our team is our foundation. We work diligently and inclusively to identify areas for transformative improvements.
We solve.
Our engineers plan, prototype, test, and repeat. We develop solutions that are as simple as possible, but no simpler.
We influence people.
We deliver value by design to providers and patients. Our mission is to drive better people outcomes.
Our Dedication to Quality
Our team pursues engineering excellence through its embrace of quality standards. Our quality policy reflects our work philosophy:
We are committed to providing safe and effective products that improve the quality of life for the people we serve.
We are dedicated to continuously improving the effectiveness of our quality management systems, products, and services by meeting customer expectations and regulatory requirements.
Our commitment to quality is reflected by our partners. Our products are designed, manufactured, and tested to ensure that they meet the quality standards the medical device industry demands. We have implemented processes compliant with ISO 13485, the medical industry’s quality management standard. Likewise, we expect our critical partners and manufacturers to also follow ISO 13485 requirements. Lazurite is certified bi-annually by the global certification body NQA.
Compliance and Ethics
Integrity
Ethics and integrity are key to establishing and maintaining trust. We know that in medtech, though, the pressure to move fast can strain—or even break—the bonds of trust.
At Lazurite, we aim to maintain a standard of open, honest communication and a steadfast commitment to legal and ethical conduct. We invite our employees to provide each other with in-person feedback on experimental design, data integrity, and reliable sources for marketing claims, to begin. This conduct includes our interactions and transactions with our customers, employees, suppliers, partners, shareholders, community, and competitors.
As part of this commitment, we have adopted the AdvaMed Code of Ethics.
The AdvaMed Code of Ethics provides medical technology companies with guidance on ethical interactions and relationships with healthcare professionals. It offers a blueprint for how to build trust among employees and, in turn, how employees can conduct themselves in a trustworthy manner with one of our key constituencies.
Partners and Collaborators
Tracy Wise and Maria Summers of CHAMPS GPO staff the Lazurite booth at AANA.
Partners
Collaborators
To know what’s next in agile surgical care, subscribe to our newsletter.
